STABLE ANTIEMETIC EMULSIONS
Emulsion formulations and systems for the intravenous or parenteral administration. of neurokinin-1 (NK-1) receptor antagonists for treatment of emesis are provided. Methods for preparing the stable NK-1 receptor antagonist emulsions and pharmaceutical formulations are further provided. The emulsion...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
26.05.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Emulsion formulations and systems for the intravenous or parenteral administration. of neurokinin-1 (NK-1) receptor antagonists for treatment of emesis are provided. Methods for preparing the stable NK-1 receptor antagonist emulsions and pharmaceutical formulations are further provided. The emulsion formulations are prepared and characterized as a formulation and process that will allow an NK-1 receptor antagonist compound to be incorporated into an emulsion for intravenous injection and remain stable during the shelf life of the formulation. Specifically, emulsion formulations have an oil phase that includes oil, ethanol, egg lecithin, and the further addition of sodium oleate that is mixed with an aqueous phase and processed to form the emulsion formulation. |
---|---|
Bibliography: | Application Number: US202117531216 |